logo
Govt urged to steer Asean beyond economic output

Govt urged to steer Asean beyond economic output

The Sun2 days ago
PETALING JAYA: Renowned humanitarian and Mercy Malaysia founder Tan Sri Dr Jemilah Mahmood has urged Malaysia to use its Asean chairmanship as a turning point not just for the region's economic ambitions but to also redefine progress through the lens of genuine well-being and planetary health.
Speaking on 'The Game of Impossible' podcast on Friday, Jemilah stressed that gross domestic product (GDP) alone is a flawed and outdated metric of development.
She said high income does not always equate to happiness or safety.
'GDP alone is a bad measure of development. You have seen countries with high GDPs but very unhappy people, very unsafe. We need a well-being economics model in which everyone can live a good life with dignity and enough economic development,' she said.
Jemilah, who founded Mercy Malaysia in 1999 after being moved by wartime footage from Kosovo, reflected on how humanitarian work has evolved from reactive disaster response to addressing the root causes of human vulnerability.
She recounted a life-changing moment from 2000, when images of a Mozambican woman giving birth atop a mango tree during severe flooding left a lasting impression.
Years later, while serving as Under Secretary-General of the International Federation of Red Cross and Red Crescent Societies, she visited Mozambique and discovered that the boy she was playing with was that very baby.
'That was my 'aha' moment,' she said.
'Have I been putting band-aids on gaping wounds? Until and unless we tackle the underlying drivers of why people are becoming so vulnerable, we can't keep (applying) aid as a cure.'
That realisation drove her deeper into planetary health, a field linking the well-being of humanity to the state of the Earth's natural systems.
Upon returning to Malaysia from Switzerland during the Covid-19 pandemic, Jemilah established the Sunway Centre for Planetary Health, envisioning it as a regional hub to address intertwined challenges such as climate change, social inequality and sustainable growth.
'Asia Pacific is the most vulnerable region in the world,' she warned, urging Malaysia to lead boldly during its Asean chairmanship with real commitments to decarbonisation, halting deforestation and driving behavioural change.
She highlighted Costa Rica as an inspiring example, a country that abolished its military, invested in environmental conservation and built a thriving ecotourism sector while consistently ranking among the world's happiest nations.
'I would rather live well than be extremely wealthy. You may have wealth but no health. We need to find the balance between well-being and wealth,' she said.
Reflecting on over two decades in humanitarian service, from conflict zones in Iraq and Afghanistan to the 2004 tsunami in Aceh, Jemilah shared searing memories, including an ambush in Iraq that claimed the lives of her colleagues and left her needing months of therapy.
'Humanitarian workers were no longer sacrosanct. International humanitarian law had been breached,' she said, describing how their clearly marked ambulance was deliberately targeted.
Through it all, Jemilah emphasised the values of humility, persistence and gratitude.
She said true leadership includes knowing when to step aside as she did by preparing a succession plan before stepping down from Mercy Malaysia.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

A step closer to enhanced elders' rights
A step closer to enhanced elders' rights

The Star

time16 hours ago

  • The Star

A step closer to enhanced elders' rights

KUALA LUMPUR: The government has completed the draft for the Senior Citizens Bill, which aims to protect the rights and well-being of the elderly, says Datuk Seri Nancy Shukri. The Women, Family and Community Development Minis­ter said it is expected to be tabled in Parliament next year. Nancy said her ministry plans to submit the draft to the Attorney-General's Chambers by the end of this year. At the moment, she said, the ministry is engaging in further consultations with industry players and state governments, including those in Sabah and Sarawak. 'What we are doing now is that we need to go back to the industry players, the stakeholders, to talk to them again. And we also have to refer to every state. 'So this is an ongoing thing because the Bill is not just for us in the peninsula. It's also for various states, especially those in the Borneo side,' she told a press conference after launching the Asean + Republic of Korea Conference on Care and Support for Older Persons here yesterday, Bernama reported. Also present were Deputy Women, Family and Community Development Minister Datuk Seri Dr Noraini Ahmad and Ambassador of the Republic of Korea to Asean, Lee Jang-keun.

New hospital to open next month
New hospital to open next month

The Star

time18 hours ago

  • The Star

New hospital to open next month

Hospital Pasir Gudang is expected to reduce the patient load at two Johor Baru hospitals. AFTER a five-year wait, Johor's Hospital Pasir Gudang (HPG) is set to open in phases starting next month. Johor health and environment committee chairman Ling Tian Soon said the RM380mil hospital would begin operations by running its emergency and trauma department and general surgery department. 'The rest of the 304-bed hospital will open up in stages. 'Once fully operational next year, the hospital will have 14 specialist clinics. 'We want to ensure that all the specialist clinics are ready with the respective specialist doctors, medical team and equipment before taking in patients.' Ling said the hospital had appointed people to key positions such as director and deputy directors and was in the process of filling more than 1,800 vacancies as approved by the Health Ministry. So far, over 270 positions had been filled, he said, adding that more vacancies would be filled by August. He said the state government had asked the ministry to station doctors and nurses at HPG or transfer them from other existing healthcare facilities, and this would take time. Ling said construction for the hospital began in 2020 but there were significant setbacks due to the Covid-19 pandemic and movement restrictions. The hospital was completed earlier this year. At full capacity, HPG is expected to cater to 900,000 residents in Pasir Gudang and its surrounding areas. It is also expected to reduce the patient volume at Hospital Sultanah Aminah (HSA) and Hospital Sultan Ismail, both located in Johor Baru. Ling said the ministry was preparing a proposal for another major healthcare project in Johor – the construction of a 1,500-bed HSA 2 near Uni­versiti Teknologi Malaysia, Sku­dai. 'The proposal will be handed over to the Public Pri­vate Partnership Unit hopefully by this month, for it to be brought to the Cabinet to discuss its implementation. 'The land matters have been sorted out and technical workshops have also been held to look into what is needed for HSA 2. 'We have another major project at the existing HSA, which is to add a new building called Ambulatory Care Centre, so we want to make sure there are no conflicts between both projects.' Previously, Ling reportedly said the HSA 2 project was to begin development in 2026 with a public-private partnership model as announced by Prime Minister Datuk Seri Anwar Ibrahim in his Budget 2025 speech. HSA 2 will be built on a 28.33ha land provided by the Defence Ministry from a 202.34ha site, making it the largest hospital in Johor.

First Lung Organoid with Organ-Specific Blood Vessels
First Lung Organoid with Organ-Specific Blood Vessels

Malaysian Reserve

timea day ago

  • Malaysian Reserve

First Lung Organoid with Organ-Specific Blood Vessels

Advanced lab-grown tissues help show how special lung cells develop, shedding light on rare ACDMPV disease and suggesting potential ways to repair damage from viral infections such as COVID-19 CINCINNATI, June 30, 2025 /PRNewswire/ — A team of experts at Cincinnati Children's reports another powerful step forward in organoid medicine: success at making human lung tissue that can produce its own blood vessels. Their findings, published in the same month as a similar success involving liver organoids, reflect a new wave of advanced lab-grown tissues that can be used immediately in many research applications while moving ever closer to serving as living tissues that can directly repair damaged organs. Details were posted online June 30, 2025, in the journal Cell. 'Prior to our study, the development of lung organoids with organotypic vasculature had not been achieved,' says co-corresponding author Mingxia Gu, MD, PhD. 'Notably, this method also could be applied to other organ systems such as intestine and colon.' Gu, now at UCLA, was a member of the Center for Stem Cell and Organoid Medicine (CuSTOM) and Division of Pulmonary Biology at Cincinnati Children's while this research was conducted. Co-first and co-corresponding author Yifei Miao, PhD, (now at the Chinese Academy of Sciences, Beijing) also was with Cincinnati Children's for this work. Co-corresponding author Minzhe Guo, PhD, remains with Cincinnati Children's along with several co-authors involved in this study. Overcoming a major challenge Researchers have been working for years to grow organoids — sometimes called 'organs in a dish.' Creating organoids involves converting mature human cells (such as blood or tissue cells) back into fetal-like stem cells that can be coaxed into growing a wide range of other tissue types. Unlike disconnected human cells kept alive in a dish, these are growing, developing mini-organs that form into seed-sized spheres that mimic the unique functions of full-sized organs. Intestines that absorb and secrete. Stomachs that produce digestive acids. Hearts that pulse. Brain tissues with firing nerve cells and so on. Cincinnati Children's has been a leader in organoid development since 2010 when experts here produced the world's first functional intestinal organoid grown from induced pluripotent stem cells (iPSCs). More recently, the challenge has been learning how to grow organoid tissues that can connect with the rest of the body to integrate nerve connections, blood vessels, bile ducts, immune systems and more. During pregnancy, these differing tissue types naturally find each other as the fetus matures and becomes more complex. Organoid developers seek to re-produce these steps in the laboratory, which eventually may allow people to receive custom-grown tissues that could patch damage or boost disrupted functions. Simpler forms of organoids have already begun transforming medical research, allowing many scientists to use living human tissue models to study disease while reducing current reliance on animal models to develop new medicines. But without the ability to make internal blood vessels, the tiny seeds lack the ability to grow into larger, more useful tissues. How the team solved the vascular riddle The new study thoroughly recounts the results of many experiments the team conducted to demonstrate success at inducing blood vessel formation. The work spanned four years and involved more than 20 people at Cincinnati Children's plus collaborations with experts at several other organizations. 'The challenge in vascularizing endodermal organs, particularly the lung, stems from different signaling requirements for lung epithelial versus vascular differentiation,' says Miao. 'Our success in this endeavor is attributable to our unique differentiation method.' In essence, the team grew iPSCs from multiple cell types then found the right moment to introduce them to each other. The resulting cell signals helped flip a developmental switch so that progenitor cells that could have become either blood vessels or the outer walls of the lung wound up becoming blood vessels. In achieving this vital step, the team: Produced lung organoids that include respiratory bronchial epithelial cells (RAS cells), a human cell type not previously reported in conventional lung organoid models. Pinned down the developmental moments when a rudimentary gut tube begins to send some cells to form the lungs while sending other cells to form the stomach and intestine. While the basic steps of this transformation have been studied in animals, it had not been possible to study this stage of development in humans without killing fetuses. Demonstrated that the rare disease ACDMPV occurs when cell signaling 'crosstalk' gets disrupted during this early blood vessel formation stage. Within days of birth, infants born with Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins (ACDMPV) struggle to breathe because their lungs' air sacs (alveoli) and blood vessels are malformed. Nearly all infants with this condition die within the first month of life, according to the National Organization for Rare Disorders. Revealed key functional information about the cells involved in gas exchange inside the human lung. Their learnings help explain the damage within tiny blood capillaries that occurs in the lungs in response to injuries. These new clues offer fresh ideas for developing ways to protect and potentially restore affected lung tissues. What's Next? Cincinnati Children's has filed patent applications related to the methods developed here to produce organoids with blood vessel formation capabilities and the CuSTOM team is moving to further develop this technology. 'We look forward to continuing to learn more about the fundamental biology involved in organ formation and applying those discoveries to improving outcomes across a wide range of difficult human diseases and conditions,' says Aaron Zorn, PhD, co-director of CuSTOM and director of the Division of Developmental Biology. In addition to publishing these findings in Cell, co-authors plan to present their work at the Keystone conference in Kyoto, Japan (iPSCs: Progress, Opportunities, and Challenges) in January 2026. About the study Cincinnati Children's co-equal first authors were Miao, Nicole Pek, BS, and Cheng Tan, MD. Contributing co-authors from Cincinnati Children's were Cheng Jiang, MS, Zhiyun Yu, PhD, Kentaro Iwasawa, MD, PhD, Min Shi, MD, PhD, Daniel Kechele, PhD, Nambirajan Sundaram, PhD, Victor Pastrana-Gomez, MSTP student, Debora Sinner, PhD, Cheng-Lun Na, PhD, Keishi Kishimoto, PhD, Jason Tchieu, PhD, Jeffrey Whitsett, MD, Kyle McCracken, MD, PhD, Michael Helmrath, MD, James Wells, PhD, Takanori Takebe, MD, PhD, and Aaron Zorn, PhD. Contributing co-authors included experts from Harvard Medical School, Icahn School of Medicine at Mount Sinai, Sophia Children's Hospital (The Netherlands), Boston University This research also was supported by the Discover Together Biobank, the Bio-Imaging and Analysis Facility, and the Integrated Pathology Research Core at Cincinnati Children's and the University of Cincinnati Proteomics Laboratory. Funding sources for this work included: the National Institutes of Health (R01HL166283, DK128799-01, N01-75N92020C00005 and R01HL095993); an Endowed Scholar Award from the Cincinnati Children's Research Foundation; the American Heart Association (1013861 and 906513); the Falk Transformational Awards Program; and the Brigham Research Institute. Learn more about working with CuSTOM Learn how donors can support ongoing organoid research at Cincinnati Children's

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store